| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Dec 04, 2024 | Sale | $5.00 | 58,184 | 290,996 | 14,117,512 | Dec 06, 2024, 05:50 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Dec 05, 2024 | Sale | $5.01 | 640,048 | 3,204,144 | 13,477,464 | Dec 06, 2024, 05:50 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Dec 06, 2024 | Sale | $5.01 | 183,728 | 920,312 | 13,293,736 | Dec 06, 2024, 05:50 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Dec 02, 2024 | Sale | $5.00 | 1,600 | 8,000 | 14,175,696 | Dec 02, 2024, 07:20 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Nov 27, 2024 | Sale | $5.00 | 12,936 | 64,680 | 14,276,000 | Dec 02, 2024, 07:20 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Nov 29, 2024 | Sale | $5.01 | 98,704 | 494,142 | 14,177,296 | Dec 02, 2024, 07:20 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Nov 25, 2024 | Sale | $5.00 | 1,600 | 8,000 | 14,289,736 | Nov 26, 2024, 06:36 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Nov 26, 2024 | Sale | $5.00 | 800 | 4,000 | 14,288,936 | Nov 26, 2024, 06:36 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Nov 11, 2024 | Sale | $5.00 | 2,400 | 12,000 | 14,291,336 | Nov 13, 2024, 04:57 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Nov 04, 2024 | Sale | $4.39 | 80,784 | 354,448 | 14,293,736 | Nov 05, 2024, 05:40 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Nov 01, 2024 | Sale | $4.38 | 48,888 | 213,939 | 14,374,520 | Nov 05, 2024, 05:40 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Nov 01, 2024 | Option Exercise | $4.24 | 245,952 | 1,043,132 | 14,423,408 | Nov 01, 2024, 07:14 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Oct 24, 2024 | Sale | $4.38 | 141,360 | 618,761 | 13,672,560 | Oct 25, 2024, 07:55 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Oct 25, 2024 | Sale | $4.38 | 3,200 | 14,000 | 13,669,360 | Oct 25, 2024, 07:55 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Oct 22, 2024 | Sale | $4.38 | 159,344 | 698,708 | 13,813,920 | Oct 22, 2024, 08:45 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Oct 18, 2024 | Sale | $4.38 | 249,728 | 1,093,983 | 14,089,960 | Oct 22, 2024, 08:45 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Oct 21, 2024 | Sale | $4.38 | 116,696 | 511,082 | 13,973,264 | Oct 22, 2024, 08:45 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Sep 11, 2024 | Sale | $3.76 | 600,000 | 2,254,080 | 14,339,688 | Sep 13, 2024, 04:15 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Aug 12, 2024 | Sale | $3.13 | 1,600 | 5,008 | 15,338,088 | Aug 14, 2024, 04:15 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Aug 13, 2024 | Sale | $3.20 | 398,400 | 1,275,540 | 14,943,424 | Aug 14, 2024, 04:15 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Aug 07, 2024 | Option Exercise | $2.62 | 314,800 | 824,776 | 15,339,688 | Aug 09, 2024, 07:11 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Aug 01, 2024 | Option Exercise | $2.83 | 88,544 | 250,801 | 14,854,488 | Aug 05, 2024, 09:30 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | May 01, 2024 | Option Exercise | $1.93 | 88,544 | 171,005 | 14,943,032 | May 03, 2024, 07:23 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Feb 01, 2024 | Option Exercise | $2.29 | 480,664 | 1,102,547 | 15,031,576 | Feb 05, 2024, 06:09 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Nov 01, 2023 | Option Exercise | $1.74 | 809,008 | 1,410,748 | 15,512,240 | Nov 03, 2023, 08:08 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Aug 07, 2023 | Sale | $2.47 | 8,616 | 21,263 | 15,521,248 | Aug 07, 2023, 09:17 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Aug 03, 2023 | Sale | $2.54 | 117,272 | 297,754 | 15,679,864 | Aug 07, 2023, 09:17 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Aug 04, 2023 | Sale | $2.50 | 150,000 | 374,880 | 15,529,864 | Aug 07, 2023, 09:17 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Aug 01, 2023 | Sale | $2.68 | 105,944 | 283,824 | 15,870,840 | Aug 03, 2023, 08:31 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Aug 02, 2023 | Sale | $2.59 | 73,704 | 191,114 | 15,797,136 | Aug 03, 2023, 08:31 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | May 01, 2023 | Sale | $2.58 | 455,528 | 1,173,395 | 15,976,784 | May 03, 2023, 07:48 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Feb 01, 2023 | Sale | $2.56 | 413,168 | 1,056,553 | 16,432,312 | Feb 03, 2023, 06:19 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Dec 20, 2022 | Sale | $2.12 | 600,000 | 1,269,060 | 16,845,480 | Dec 21, 2022, 04:05 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Nov 01, 2022 | Option Exercise | $1.60 | 454,856 | 727,770 | 17,458,640 | Nov 03, 2022, 04:05 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Nov 01, 2022 | Sale | $1.67 | 13,160 | 22,011 | 17,445,480 | Nov 03, 2022, 04:05 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Aug 09, 2022 | Sale | $1.75 | 600,000 | 1,050,000 | 14,313,496 | Aug 11, 2022, 09:45 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Aug 01, 2022 | Option Exercise | $0.67 | 454,856 | 305,891 | 14,926,664 | Aug 03, 2022, 04:10 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Aug 01, 2022 | Sale | $0.70 | 13,168 | 9,215 | 14,913,496 | Aug 03, 2022, 04:10 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | May 03, 2022 | Sale | $0.50 | 12,512 | 6,201 | 15,381,520 | May 05, 2022, 07:18 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | May 01, 2022 | Option Exercise | $0.52 | 432,128 | 225,787 | 15,394,032 | May 03, 2022, 08:18 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Feb 01, 2022 | Option Exercise | $0.78 | 288,320 | 223,794 | 15,836,576 | Feb 03, 2022, 05:54 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Feb 02, 2022 | Sale | $0.76 | 10,416 | 7,877 | 15,826,160 | Feb 03, 2022, 05:54 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Feb 01, 2022 | Option Exercise | $0.75 | 133,776 | 99,998 | 16,124,896 | Feb 03, 2022, 05:54 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Nov 01, 2021 | Option Exercise | $0.64 | 454,848 | 291,103 | 16,001,536 | Nov 03, 2021, 07:51 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Nov 02, 2021 | Sale | $0.65 | 10,416 | 6,721 | 15,991,120 | Nov 03, 2021, 07:51 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Aug 01, 2021 | Option Exercise | $0.79 | 454,840 | 357,049 | 16,466,800 | Aug 03, 2021, 09:45 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Aug 02, 2021 | Sale | $0.77 | 10,416 | 7,989 | 16,456,384 | Aug 03, 2021, 09:45 PM | |
| VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Officer | Mar 01, 2021 | Sale | $1.14 | 26,728 | 30,571 | 19,054,504 | Mar 03, 2021, 08:05 PM | |
| DOVA | Dova Pharmaceuticals Inc. | Hahn Mark W | Chief Financial Officer | Sep 30, 2019 | Sale | $28.00 | 775 | 21,700 | 9,024 | Oct 02, 2019, 04:20 PM | |
| DOVA | Dova Pharmaceuticals Inc. | Hahn Mark W | Chief Financial Officer | Jul 01, 2019 | Sale | $14.17 | 1,545 | 21,893 | 9,799 | Jul 02, 2019, 04:59 PM | |
| DOVA | Dova Pharmaceuticals Inc. | Hahn Mark W | Chief Financial Officer | Dec 19, 2018 | Buy | $6.28 | 2,500 | 15,700 | 2,500 | Dec 21, 2018, 05:05 PM |
Menu